Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PIR-FIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
B3GALNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM193B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF81 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PET117 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
OTX2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNM1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on